Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-005207
Filing Date
2021-02-08
Accepted
2021-02-08 17:40:19
Documents
2
Period of Report
2021-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3963
2 EX-24 DOCUMENT attachment1.htm EX-24 4072
  Complete submission text file 0000899243-21-005207.txt   9671
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

EIN.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103
Business Address
Harwin Peter Evan (Reporting) CIK: 0001663607 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36483 | Film No.: 21602777